CC BY-NC-ND 4.0 · J Lab Physicians 2020; 12(04): 268-270
DOI: 10.1055/s-0040-1722551
Original Article

Stability of SARS-CoV-2 RNA in Viral Lysis Buffer Stored at Different Temperatures

1   State Virology Laboratory, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Rajeev Kumar Jain
1   State Virology Laboratory, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Rakesh Shrivastava
2   Department of Microbiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Jaya Lalwani
2   Department of Microbiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Deepti Chaurasia
2   Department of Microbiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
› Author Affiliations

Abstract

Objectives The present COVID-19 pandemic resulted in an increased need for molecular diagnostic testing. Delay in the specimen processing and suboptimal storage of suspected samples in laboratories leads to degradation of SARS-CoV-2 viral RNA. Viral lysis buffers from RNA extraction kits have the potential to stabilize RNA. Hence, this study aimed to investigate the stability of SARS-CoV-2 RNA in viral lysis buffer at different temperatures and time periods.

Materials and Methods Aliquots of samples with known SARS-CoV-2 RNA were processed in viral lysis buffers simultaneously, stored separately at 2 to 8°C and 22 to 28°C for 24 hours, 48 hours and 72 hours. SARS-CoV-2 viral RNA was extracted from each aliquot and analyzed using multiplex real-time PCR.

Results SARS-CoV-2 RNA in samples placed in viral lysis buffer was stable for 48 hours at both 2 to 8°C and 22 to 28°C temperatures. Slight decline in the viral RNA quantity was found on aliquots tested after 48 hours of both the temperatures.

Conclusions Viral lysis buffer maintains the integrity of SARS-CoV-2 RNA for up to 48 hours even at room temperature and supports delayed diagnosis with an overwhelming sample load in testing laboratories.



Publication History

Article published online:
30 December 2020

© 2020. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55 (03) 105924
  • 2 Sohrabi C, Alsafi Z, O’Neill N. et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-76
  • 3 van Kasteren PB, van der Veer B, van den Brink S. et al. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 2020; 128: 104412
  • 4 Scallan MF, Dempsey C, Mcsharry J, O’callaghan I. Validation of a lysis buffer containing 4 M Guanidinium validation of a lysis buffer containing 4 M Guanidinium Thiocyanate (GITC)/Triton X-100 for extraction of SARS-CoV-2 Thiocyanate (GITC)/ Triton X-100 for extraction of SARS-CoV-2. bioRxiv 2020 (e-pub ahead of print). doi: https://doi.org/10.1101/2020.04.05.026435
  • 5 Amellal B, Murphy R, Maiga A. et al. Stability of HIV RNA in plasma specimens stored at different temperatures. HIV Med 2008; 9 (09) 790-793
  • 6 Liu H, Gan Y, Wu Y, Weng H, Lei P, Shen G. Effects of different lysis buffers of nucleic acid purification kit on the stability of influenza virus RNA. Future Virol 2014; 9 (06) 549-555
  • 7 Ngo KA, Jones SA, Church TM. et al. Unreliable inactivation of viruses by commonly used lysis buffers. Appl Biosaf 2017; 22 (02) 56-59
  • 8 Anwar A, Wan G, Chua K. et al. Evaluation of pre-analytical variables in the quantification of dengue virus by real-time polymerase chain reaction. Available at: https://www.sciencedirect.com/science/article/pii/S1525157810602760. Accessed May 24, 2020